about
Aberrant right retroesophageal subclavian artery causing esophageal compression.Malignant tumours of the small intestine.Complications of bariatric surgery--What the general surgeon needs to know.Adherence to clinical guidelines and the potential economic benefits of admission avoidance for acute uncomplicated diverticulitis.Endoscopic tattooing to aid tumour localisation in colon cancer: the need for standardisation.A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.C-reactive protein as a predictor of anastomotic leak in the first week after anterior resection for rectal cancer.Liberal perioperative fluid administration is an independent risk factor for morbidity and is associated with longer hospital stay after rectal cancer surgery.Magnitude of non-operative surgical emergency admissions; service implications for surgical and radiological practice.Breaking Barriers to Successful Implementation of Day Case Laparoscopic Cholecystectomy.An unusual cause of dyspnea and tachycardia.Health-related quality of life of HIV-infected intravenous drug users.A Case of Primary Invasive Aspergillus Colitis Masquerading as Clostridium difficile Infection.The Utility of Neutrophil to Lymphocyte Ratio as a Predictor of Intervention in Acute Diverticulitis.A bone of contention.Implementation of day of surgery admission for rectal cancer surgery in Ireland following a national centralisation programmeThirty-seven-year Population-based Study of Colorectal Cancer Rates in Renal Transplant Recipients in IrelandResponse to: shift in paradigm of clinical management of anastomotic leakMucin Pools Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Marker of Response or Epiphenomenon?Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancersMucinous adenocarcinoma of the colon and rectum: A genomic analysisThe significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancerMucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancerMeta-analysis of the molecular associations of mucinous colorectal cancer
P50
Q36188428-47E0C5C9-4E26-4A12-A3FA-DB5221C0EF56Q38196624-3E36D4AF-2F71-4893-86CE-B22D24A7161CQ38582082-B5E5B20B-6DAD-4A6D-B58E-25C472A9165AQ38762075-2E7CFF1B-5080-4373-906C-088B5BC59990Q38958812-CC1063D2-8B86-467C-BB5B-29AE2C5B7687Q39025783-6A18E000-1CF9-4F19-BF09-40C821E5F46CQ39168580-D1854CD4-6C4E-4A52-9A8B-422E49FE5FA1Q39360664-2AEEC697-51CD-4612-843A-26D442FD893DQ39379719-876F3481-0563-4ABE-B59C-93DA87A46AC4Q40562757-E06EB8EC-A936-4948-A1F4-A73EF16B30F1Q41062421-E597EC7F-475E-4D72-B080-29599F09D26BQ42250158-8633DED7-25B2-4501-A863-4ED4779EC5F3Q44646591-894A1011-79CF-4F57-9F90-B67FCC572BA0Q51273863-FDF8026E-518D-4E36-BFB3-0BBD5A28B073Q54412746-1F56BB69-615E-42B7-BD51-FDF7385244BBQ57020530-16F61585-512C-4736-A631-8FE2BE2DDBCCQ64119342-D11A7724-410C-4F01-BA5D-CBC67C149906Q88610862-747D8149-62B6-42E0-8BC7-4BE63751E8C1Q90368358-5341DD37-EFC0-4BC5-ADEA-07A5D8276561Q91214819-8013F197-08A8-4A5B-97CA-FDCF1C394EF1Q91290461-9ECEFF7B-4034-4A05-85B6-F1B4274FD754Q91810846-13E76C63-8ADA-42D1-9076-91AB19208A5BQ91826162-0C517161-9F41-4569-AFDD-C6E2586D64A5Q92841197-94CCE63D-5AA4-4302-8882-F569B9BACCAA
P50
description
researcher ORCID ID = 0000-0002-8790-2538
@en
name
I Reynolds
@ast
I Reynolds
@en
I Reynolds
@nl
type
label
I Reynolds
@ast
I Reynolds
@en
I Reynolds
@nl
prefLabel
I Reynolds
@ast
I Reynolds
@en
I Reynolds
@nl
P108
P31
P496
0000-0002-8790-2538